Every 36 seconds, someone in the US dies of cardiovascular disease.4

It is our nation’s leading cause of death, yet it’s often misunderstood.4 Although sometimes referred to as heart disease, cardiovascular disease actually refers to several conditions that can affect more than just the heart.5 One serious condition that is often underdiagnosed and undertreated is peripheral artery disease, or PAD.3 PAD is a common circulatory condition that occurs when a buildup of plaque in the blood vessels causes a reduction in blood flow to the limbs, most often the legs.1 PAD is associated with serious outcomes, including heart attack and stroke.1 If left untreated, it can result in amputation of the affected limbs.1

Janssen has created the Save Legs. Change Lives.TM Spot Peripheral Artery Disease Now initiative to raise awareness about this serious condition and encourage screening to make sure it doesn’t go undiagnosed.

Black Americans have the highest risk for PAD.2 They are more likely to develop the condition and more likely to require amputation as a result.2 Through Save Legs. Change Lives.TM, Janssen has joined forces with leading professional associations, healthcare systems, and community organizations to address these inequalities and to help ensure health equity for everyone.

Save Legs. Change Lives.TM

Has Three Areas of Focus:

Empowering Individuals: Man in workout gear stretching his legs

Empowering Individuals and Communities

by supporting PAD awareness, education, and screening that help those at risk change the trajectory of their health.

PAD Education
Patient Resources

Collaborating with Partners

including universities, health systems, and advocacy groups, to support and drive programs that help eliminate health inequities.

Our Commitments
Collaborating with Powerful Partners: Doctor having conversation with colleagues
Driving Research: Woman working in a lab environment

Driving Research

that paves the way for establishing routine PAD screening and equitable care for communities placed at an increased risk of PAD.